CVE-2026-57496
Labs64 NetLicensing-MCP
- Labs64 NetLicensing-MCP
- Critical
- CVSS 9.6
- EPSS 0.35%
- No fixed version listed
What to do
No fixed version listed
Affected products
| Product | Affected | Fixed in |
|---|---|---|
| Labs64 NetLicensing-MCP | < 0.1.8 | None listed |
Advisories and fixes
- Public exploit github.com
Scores and signals
- Exploitation
- No known exploitation
- Severity
- Critical, CVSS 9.6 (v3.1, scored by GitHub_M)
- EPSS
- 0.35% chance of exploitation in the next 30 days (EPSS from FIRST, as of Oct 23, 2026)
- CISA's SSVC decision points
- Exploitation: proof of concept. Automatable: no. Technical impact: total. As of Oct 21, 2026.
- Weakness
- CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
- Vendor
- Labs64, NetLicensing-MCP
Timeline
- First listed as critical by cve.now. Affected and fixed versions come from the CVE record, once one is published.